Treace Medical Concepts Inc.
TMCI | undefined
-
At close: undefined
-
After-hours:
Market Data
Market Cap $290.63M
Enterprise Value $258.1M
Beta 1.41
Average Volume 622.8K
Shares Outstanding (Diluted) 65.05M
Shares Change YoY 3.24%
Institutional Ownership 55.71%
Exchange NASDAQ
ISIN US89455T1097
Price Performance
Price Change 1M 3.2%
Price Change 3M -0.2%
Price Change 6M 255.6%
Price Change YTD 79.2%
Price Change 1Y -35.1%
Price Change 3Y -66.5%
Price Change 5Y -84.7%
1M CAGR (ann.) -5.9%
1Y CAGR (ann.) -37.7%
5Y CAGR (ann.) -30.5%
All-Time CAGR -27.5%
Valuation
PE Ratio -4.82
Forward PE N/A
PEG Ratio 0.27
Forward PEG 0.55
PS Ratio 1.42
Forward PS 1.30
PB Ratio 4.29
P/FCF Ratio -11.60
P/Adj. FCF Ratio -5.27
P/OCF Ratio -20.36
EV/Sales 1.26
EV/EBIT -6.55
EV/EBITDA -5.40
EV/FCF -10.31
Earnings Yield -20.8%
FCF Yield -8.6%
Adj. FCF Yield -19.0%
Financial Health
Net Cash $32.53M
Total Debt $13.09M
Cash & Short-Term Investments $45.62M
Total Assets $181.06M
Current Ratio 2.90
Quick Ratio 1.95
Debt / Equity Ratio 1.07
Debt / EBITDA -0.27
Debt / FCF -0.52
OCF / Debt -1.11
Interest Coverage -9.23
Altman Z-Score 0.29
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 79.5%
Operating Profit Margin -26.2%
EBITDA Margin -22.0%
Net Profit Margin -29.0%
FCF Margin -12.2%
Adj. FCF Margin -26.8%
SBC / Revenue 10.7%
SBC Impact (per share) -120.0%
Returns
Return on Assets -32.9%
Return on Equity -74.1%
Return on Invested Capital -37.5%
Return on Capital Employed -38.5%
Return on Tangible Assets -36.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 7.1%
Revenue CAGR 5Y 21.4%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 4.9%
EPS CAGR 5Y -5.7%
EPS CAGR 10Y N/A
FCF CAGR 3Y 25.8%
FCF CAGR 5Y 13.8%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 9
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.26
EPS Growth Est (next Q) 0.0%
Revenue Est (next Q) $47.71M
Revenue Growth Est (next Q) -5.0%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $8.60
Price Target Upside 92.0%
Cash Flow
Operating Cash Flow $-14.58M
Free Cash Flow $-25.05M
Adj. Free Cash Flow $-55.1M
FCF Per Share -$0.39
OCF Per Share -$0.22
OCF/S Ratio -7.1%
Income Statement
Revenue $205.31M
Gross Profit $163.12M
Operating Income $-53.72M
EBITDA $-47.79M
Net Income $-59.52M
EPS (Diluted) -$0.93
Revenue / Employee $456.24K
Profit / Employee $-132.26K
Employees 450
Add to Watchlist
Select watchlists to add or remove TMCI